(secondQuint)Oxaliplatin in Treating Patients With Previously Treated Locally Advanced or Metastatic Colorectal Cancer.

 OBJECTIVES: - Provide oxaliplatin for patients with previously treated locally advanced or metastatic colorectal cancer who have exhausted all approved therapies for colorectal cancer.

 OUTLINE: This is a multicenter, Treatment Access Program study.

 Patients receive oxaliplatin IV over 2 hours on day 1.

 Treatment repeats every 21 days for up to 8 courses in the absence of disease progression or unacceptable toxicity.

 Patients are followed for at least 30 days.

 PROJECTED ACCRUAL: Approximately one patient per site per month will be accrued for this study.

.

 Oxaliplatin in Treating Patients With Previously Treated Locally Advanced or Metastatic Colorectal Cancer@highlight

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.

 PURPOSE: Clinical trial to study the effectiveness of oxaliplatin in treating patients who have locally advanced or metastatic colorectal cancer that has been previously treated.

